ATC Abstracts

American Transplant Congress abstracts

2017 American Transplant Congress

April 29-May 3, 2017 in Chicago, IL

View by Title View Sessions
View by Date

Sunday, April 30, 2017

3:42pm-3:54pm
Assessing Self-Efficacy During the Transition from Pediatric to Adult Liver Transplant Care.

J. Bilhartz, M. Lopez, S. Eder, E. Fredericks.

Concurrent Session: Pediatric Liver  •  E271a
3:42pm-3:54pm
BK Virus, Cytomegalovirus and Epstein-Barr Virus Reactivation in Renal Transplant Patients: Results from a Large Multicenter Study.

A. Blázquez-Navarro,1 C. Dang-Heine,1 M. Or-Guil,2 C. Bauer,3 T. Westoff,4 C. Hugo,5 P. Reinke,1 B. Sawitzki,1 N. Babel.1,4

Concurrent Session: Cutting Edge - Cytomegalovirus  •  E353C
3:42pm-3:54pm
Glycolytic and Glutaminolytic Metabolism Supports IL-15 Induced Inflammatory Response of Temra CD8 from Kidney Transplant Recipients.

T.-M. Doan-Ngoc,1 G. Tilly,1 M. Yap,1 A. Caristan,1 L. Jacquemont,1 R. Danger,1 M. Cadoux,1 S. Bruneau,1 M. Giral,1 P. Guerif,1 B. Nicol,1 A. Garcia,1 D. Laplaud,1 S. Brouard,1 C. Pecqueur,2 N. Degauque.1

Concurrent Session: Innate Pathways of Clinical Alloreactivity  •  E352
3:42pm-3:54pm
Incidence of De Novo Donor-Specific Antibodies Following Kidney Transplantation.

B. Ho,1 H. Bhagat,2 E. Lee,2,3 K. Atiemo,1 A. Daud,1 R. Kang,1 S. Montag,1,4 L. Zhao,1,4 J. Schwartz,2 D. Ladner.1

Concurrent Session: Kidney HLA Antibodies  •  E354b
3:42pm-3:54pm
Long-Term Outcome of Antibody-Mediated Rejection Due to Pre-Existing vs. De Novo DSA in Kidney Allograft Recipients.

O. Aubert,1 C. Lefaucheur,1 S. Higgins,1 L. Hidalgo,2 J. Duong Van Huyen,1 D. Viglietti,1 X. Jouven,1 D. Glotz,1 P. Halloran,2 A. Loupy.1

Concurrent Session: Assessing Risk for Antibody-Mediated Rejection in Kidney Transplant Recipients  •  E354a
3:42pm-3:54pm
More Rapid Decline in Male VS Female Living Kidney Donations (LKD) Varies by Income.

J. Lesage, J. Gill, C. Rose, Y. Joffres, J. Gill.

Concurrent Session: Kidney Living Donor Evaluation and Recruitment  •  E450a
3:42pm-3:54pm
Preventing of Rejection of Vascularized Composite Allografts by Targeting T Cell Metabolism.

B. Oh,1 C. Cheng,2 G. Furtmüller,1 W. Lee,1 J. Powell,2 G. Brandacher.1

Concurrent Session: VCA  •  E270
3:42pm-3:54pm
Simultaneous or Sequential Heart-Liver Transplantation Confer Superior Survival in Patients with Listed for Heart-Liver Transplantation: A National Analysis.

K. Anderson,1 M. Mulvihill,2 B. Yerokun,2 A. Barbas,2 M. Hartwig.2

Concurrent Session: Heart Waitlist and Allocation: Working to Get It Right  •  E267
3:42pm-3:54pm
Sirolimus Prolonged Survival After Living Donor Liver Transplantation for HCC Beynd Milan Criteria; Outcome of a Multicenter Prospective Randomized Phase II Trial (ClinicalTrials.gov Identifier: NCT01374750).

K.-W. Lee,1 S.-H. Kim,2 N.-J. Yi,1 S.-K. Hong,1 G. Yoon,1 H. Kim,1 D. Oh,1 S.-S. Han,2 S.-J. Park,2 K.-S. Suh.1

Concurrent Session: Clinical Science: Liver - Hepatocellular Carcinoma  •  E451b
3:42pm-3:54pm
Substance Abuse in Acute Liver Failure: Time to Talk About Opiates.

M. Jesse, N. Rebhan, A. Yoshida, D. Moonka, A. Eshelman, M. Abouljoud, M. Rizzari.

Concurrent Session: Psychosocial and Mediation Adherence Concerns  •  E271b